Inside India’s Most Valued Pharma Company: Sun Pharma Chief Dilip Shanghvi Lays Out Future Growth Plans
This article was originally published in PharmAsia News
Executive Summary
Sun Pharma chief will look for opportunities in emerging markets, but buyouts will not be large.